Discussion - Alteration in acquired von willebrand factor with centrifugal or axial flow left ventricular assist devices: a prospective, multicenter clinical trial.

27 May 2019 (09:25 - 09:30)

Organised by:

Video

Sign in for access options

11 More presentations in this session

Presentation thumbnail

Reduction of Mitral Regurgitation in Patients with Heart Failure and Secondary Mitral Regurgitation: Relationship Between Baseline Biomarkers and Outcomes from the COAPT Trial

Professor W. Abraham (Columbus, US)

Presentation thumbnail

Discussion - COAPT.

Presentation thumbnail

A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system

Professor W. Abraham (Columbus, US)

Presentation thumbnail

Discussion - A first in human multi-center, open label, prospective study to evaluate the safety, usability and performance of the V-LAP system.

Presentation thumbnail

Cardiac contractility modulation (CCM) in HFrEF NYHA Class III patients

Professor D. Burkhoff (New York, US)

Access the full session

Session thumbnail

Late breaking trial III - Innovative and device therapy

The Event

Heart Failure 2019

27 May 2019 09:25 CET

You may be interested in

Congress Presentation

Evolution of antithrombotic regimens in left ventricular assist device patients: is thrombosis still a problem?

31 August 2026

Congress Presentation

The implantation of a left ventricular assist device causes changes in the aortic miRNome and proteome - an integrative analysis

30 August 2024

Congress Presentation

3 September 2019

Congress Session

Therapeutic dilemmas in patients with left ventricular assist device (LVAD)

17 May 2025

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources

ESC 365 is supported by

novartis

Explore sponsored resources

novo-nordisk

Explore sponsored resources